Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline.
/PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws.
Pardes Biosciences (NASDAQ:PRDS – Get Free Report) and Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Earnings and Valuation This table compares Pardes […]
Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Free Report) was the target of a large drop in short interest in June. As of June 30th, there was short interest totalling 1,120,000 shares, a drop of 45.1% from the June 15th total of 2,040,000 shares. Based on an average daily trading volume, of 219,200 shares, the days-to-cover […]